Search

Search results

88 results found

Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group.

Im, Gene Y, Jessica L Mellinger, Adam Winters, Elizabeth S Aby, Zurabi Lominadze, John Rice, Michael R Lucey, et al. 2021. “Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 19 (11): 2407-2416.e8.

Altered ethanol metabolism and increased oxidative stress enhance alcohol-associated liver injury in farnesoid X receptor-deficient mice.

Morel, Caroline, Vivek Chowdhary, Prashanth Thevkar Nagesh, Marcelle Ribeiro, Danielle Hawryluk, Donna Catalano, Luciano Adorini, and Gyongyi Szabo. 2023. “Altered Ethanol Metabolism and Increased Oxidative Stress Enhance Alcohol-Associated Liver Injury in Farnesoid X Receptor-Deficient Mice.”. Liver International : Official Journal of the International Association for the Study of the Liver 43 (1): 100-114.

Reply.

Szabo, Gyongyi, Mack C Mitchell, Srinivasan Dasarathy, and Craig McClain. 2023. “Reply.”. Hepatology (Baltimore, Md.) 77 (5): E115.

Alcohol-induced extracellular ASC specks perpetuate liver inflammation and damage in alcohol-associated hepatitis even after alcohol cessation.

Ribeiro, Marcelle de Carvalho, Arvin Iracheta-Vellve, Mrigya Babuta, Charles D Calenda, Christopher Copeland, Yuan Zhuang, Patrick P Lowe, et al. 2023. “Alcohol-Induced Extracellular ASC Specks Perpetuate Liver Inflammation and Damage in Alcohol-Associated Hepatitis Even After Alcohol Cessation.”. Hepatology (Baltimore, Md.) 78 (1): 225-42.

A novel score of IL-13 and age predicts 90-day mortality in severe alcohol-associated hepatitis: A multicenter plasma biomarker analysis.

Tornai, David, Mack Mitchell, Craig J McClain, Srinivasan Dasarathy, Arthur McCullough, Svetlana Radaeva, Aimee Kroll-Desrosiers, JungAe Lee, Bruce Barton, and Gyongyi Szabo. 2023. “A Novel Score of IL-13 and Age Predicts 90-Day Mortality in Severe Alcohol-Associated Hepatitis: A Multicenter Plasma Biomarker Analysis.”. Hepatology Communications 7 (12).

Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled Study.

Tepper, Stewart J, David W Dodick, Michel Lanteri-Minet, David Dolezil, Raquel Gil-Gouveia, Christian Lucas, Karolina Piasecka-Stryczynska, et al. 2025. “Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled Study.”. European Journal of Neurology 32 (8): e70328.